| Business Name: |
Mid Florida Podiatry |
| Contact Person: |
Vincent Milione, Owner |
| Address: |
328 Fairway Pointe Circle, Orlando, Florida 32828 |
| Phone Number: |
(407) 352-9666 |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Mammino Jere DO - Orlando, FL 32828
Md Time Inc - Orlando, FL 32828
Gayoso Marcia D MD - Orlando, FL 32828
Burzynski Yolanda M MD - Orlando, FL 32828
Gutterez Michael MD - Orlando, FL 32828
Ahmed Rehan MD - Orlando, FL 32828
Marie Quinonez M D P A - Orlando, FL 32828
Primary Care Of Central Florida Inc - Orlando, FL 32828
Schwartz Eugene F MD - Orlando, FL 32828
Orlando Sports Medicine Group - Orlando, FL 32828
Malionee Ronald C MD - Orlando, FL 32828
Qazi Mohammad MD - Orlando, FL 32828
Zeffren Bernard S MD - Orlando, FL 32828
Hayne Thomas MD - Orlando, FL 32828
Rodriguez Austria MD - Orlando, FL 32828
Haughton-Green Allison MD - Orlando, FL 32828
Mallonee Ronald C DO - Orlando, FL 32828
Mallonee Ronald C MD - Orlando, FL 32828
Hudson George M MD - Orlando, FL 32828
Meloukheia Aysha MD - Orlando, FL 32828
|
The company Mid Florida Podiatry provides B2C services in the form of Doctors from its single location in Florida.
1 to 4 employees work for Mid Florida Podiatry, and the business now earns $1.000.000 to $2.499.999 per annum.
Mid Florida Podiatry was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Mid Florida Podiatry, please call Vincent Milione, Owner with the phone number (407) 352-9666 or visit its single location at 328 Fairway Pointe Circle in Orlando, Florida 32828.
The location of the single location can also be found using the coordinates 28.529588,-81.191991.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.